Skip to main content
    R

    Rockwell Medical Inc (RMTI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.98
    +0.32 (+4.18%)

    Market Cap: $31.64M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    54%(21/39)
    Avg Surprise
    +6.93%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.18
    Range$-0.23 - $-0.13
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.15-20.0%
    60d ago$-0.17-9.1%
    30d ago$-0.17-9.1%
    7d ago$-0.23+21.7%
    Current$-0.18
    Revenue Consensus
    $18M
    Range$18M - $18M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.57
    Range$-0.68 - $-0.46
    2 analysts
    Revenue Consensus
    $18M
    Range$18M - $18M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.57---
    Sep 26EST
    		-$-0.18---
    Jun 26
    Reported Aug 13
    		$-0.34$-0.17-100.00%Miss+32.0%
    Mar 26
    Reported May 7
    		$-0.40$-0.25-60.00%Miss+0.0%
    Dec 25
    Reported Mar 26
    		$-0.01N/A+77.78%Beat+50.0%
    Sep 25
    Reported Nov 12
    		$-0.50$-0.45-11.11%Miss-200.0%
    Jun 25
    Reported Aug 14
    		$-0.50$-0.50+0.00%Beat-600.0%
    Mar 25
    Reported May 12
    		$-0.40$-0.50+20.00%Beat+33.3%
    Dec 24
    Reported Mar 20
    		$-0.02$0.02-200.00%Miss+60.0%
    Sep 24
    Reported Nov 12
    		$0.50$0.10+400.00%Beat+157.5%
    Jun 24
    Reported Aug 8
    		$0.10N/A+128.57%Beat+105.9%
    Mar 24
    Reported May 14
    		$-0.60$-0.40-50.00%Miss-500.0%
    Dec 23
    Reported Mar 21
    		$-0.05$-0.07+28.57%Beat+96.4%
    Sep 23
    Reported Nov 14
    		$-0.87$-0.90+3.33%Beat+78.3%
    Jun 23
    Reported Aug 14
    		$-1.69$-1.20-40.83%Miss+69.8%
    Mar 23
    Reported May 15
    		$-0.10$-0.16+37.50%Beat+98.8%
    Dec 22
    Reported Mar 30
    		$-1.40N/A+64.10%Beat-1455.6%
    Sep 22
    Reported Nov 14
    		$-4.00$-3.70-8.11%Miss+54.5%
    Jun 22
    Reported Aug 15
    		$-5.60$-8.10+30.86%Beat+43.4%
    Mar 22
    Reported Apr 8
    		$-8.40$-7.70-9.09%Miss+4.5%
    Dec 21
    Reported Dec 31
    		$-0.09N/A+90.91%Beat+90.9%
    Sep 21
    Reported Nov 15
    		$-8.80$-8.25-6.67%Miss+20.0%
    Jun 21
    Reported Aug 16
    		$-9.90$-8.80-12.50%Miss-3.4%
    Mar 21
    Reported May 17
    		$-8.80$-9.90+11.11%Beat+33.3%
    Dec 20
    Reported Mar 31
    		$-0.99$-0.93-6.45%Miss+18.2%
    Sep 20
    Reported Nov 9
    		$-11.00$-7.70-42.86%Miss+16.7%
    Jun 20
    Reported Aug 10
    		$-9.57$-15.40+37.86%Beat+51.7%
    Mar 20
    Reported May 11
    		$-13.20$-13.20+0.00%Beat-700.0%
    Dec 19
    Reported Mar 12
    		$-1.21$-1.36+11.03%Beat+35.3%
    Sep 19
    Reported Nov 11
    		$-13.20$-17.23+23.39%Beat-1100.0%
    Jun 19
    Reported Aug 8
    		$-19.80$-17.60-12.50%Miss-718.2%
    Mar 19
    Reported May 9
    		$-1.65$-1.98+16.67%Beat-15.4%
    Dec 18
    Reported Mar 14
    		$-1.87$-1.43-30.77%Miss+90.6%
    Sep 18
    Reported Nov 9
    		$-1.10$-1.65+33.33%Beat+90.0%
    Jun 18
    Reported Aug 14
    		$-2.42$-1.43-69.23%Miss+84.3%
    Mar 18
    Reported May 10
    		$-1.43$-1.54+7.14%Beat-44.4%
    Dec 17
    Reported Mar 15
    		$-19.80$-13.20-50.00%Miss-80.0%
    Sep 17
    Reported Nov 8
    		$-11.00$-11.00+0.00%Beat-
    Jun 17
    Reported Aug 9
    		$-15.40$-11.00-40.00%Miss-
    Mar 17
    Reported May 9
    		$-0.99$-0.93-6.45%Miss-
    Dec 16
    Reported Mar 15
    		$-11.00$-11.55+4.76%Beat-

    Key Metrics

    Valuation
    P/E Ratio-6.38EV/EBITDAN/A
    Price/FCF20.51xFCF Yield4.88%
    Profitability
    Profit Margin-7.33%Operating Margin-5.97%
    ROE-15.50%ROIC-7.39%
    Financial Health
    Debt/Equity0.26xInterest Coverage0.54x
    Current Ratio3.25xQuick Ratio3.00x
    Trading Statistics
    Beta1.63Avg Volume26.10K
    52-Week High$12.9052-Week Low$4.88

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.97
    SMA 20$8.26
    SMA 50$7.96
    SMA 200$8.35
    EMA 10$7.97
    EMA 20$8.06
    EMA 50$7.90
    EMA 200$8.30

    MACD

    Line: -0.05Signal: 0.04Hist: -0.09

    ADX

    ADX: 28.3+DI: 15.7-DI: 20.8

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$8.65

    Bollinger Bands

    Upper Band$9.07
    Lower Band$7.46
    %B Position1949%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    48.9

    Momentum Oscillators

    Stoch %K28.6
    Stoch %D20.9
    Williams %R-55.1
    ROC (10d)-6.9%
    Momentum-0.59
    CCI (20d)-79.3
    MFI (14d)57.2

    Volatility Measures

    ATR (14d)$0.47(5.9%)
    StdDev (20d)0.40
    Hist Vol61.9%(High)

    Volume Flow

    VWAP$7.86
    OBV6.7M
    AD Line39.1B
    CMF (20d)0.074

    Volume Metrics

    Avg Vol (20d)28.3K
    Vol Ratio2.8x(High)
    VWMA (20d)$8.15

    Pivot Points

    R3$8.12
    R2$8.03
    R1$7.84
    Pivot Point$7.75
    S1$7.57
    S2$7.48
    S3$7.29

    Advanced Oscillators

    TSI-3.35
    Ultimate Osc49.3
    KST7.49

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17.78M$17.34M$18.35M$15.93M$16.07M$18.91M$24.66M$28.32M$25.83M$22.68M$22.09M$23.77M
    Cost of Revenue$14.54M$14.44M$14.47M$13.65M$13.57M$15.87M$21.03M$22.08M$21.28M$19.61M$19.22M$21.57M
    Gross Profit$3.24M$2.90M$3.88M$2.27M$2.50M$3.04M$3.63M$6.24M$4.55M$3.06M$2.87M$2.20M
    Operating Expenses$4.30M$4.38M$4.28M$3.86M$3.85M$4.40M$4.15M$4.30M$4.04M$4.39M$3.42M$3.94M
    R&D$40,000$0$0$0$0$0$1,000$0$0$18,000$168,000$494,000
    SG&A$3.69M$3.81M$3.74M$3.33M$3.28M$3.69M$3.31M$3.58M$3.45M$3.78M$2.71M$2.89M
    Operating Income$-1,061,000$-1,480,000$-398,000$-1,584,000$-1,349,000$-1,360,000$-519,000$1.94M$515,000$-1,324,000$-547,000$-1,737,000
    Interest Income$40,000$37,000$44,000$55,000$69,000$66,000$29,000$30,000$9,000$24,000$42,000$56,000
    Interest Expense$281,000$282,000$286,000$285,000$276,000$277,000$289,000$302,000$232,000$431,000$1.11M$411,000
    Income Before Tax$-1,172,000$-1,605,000$-554,000$-1,753,000$-1,492,000$-1,515,000$-756,000$1.66M$343,000$-1,731,000$-1,512,000$-1,872,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,172,000$-1,605,000$-554,000$-1,753,000$-1,492,000$-1,515,000$-756,000$1.66M$343,000$-1,731,000$-1,512,000$-1,872,000
    EBITDA$-349,000$-761,000$323,000$-890,000$-634,000$-677,000$136,000$2.57M$1.15M$-560,000$834,000$-861,000
    EBIT$-931,000$-1,360,000$-312,000$-1,523,000$-1,285,000$-1,304,000$-496,000$1.94M$566,000$-1,324,000$-547,000$-1,517,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RMTI

    Government Contracts

    Gov Obligations (TTM)
    -$2065
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Rockwell Medical schedules results. Rockwell Medical stock has USD 32.2 million value

    Rockwell Medical (RMTI) announced it will release its third-quarter 2026 results on November 12, 2026, with a webcast scheduled for investors. The company's market value stood at $32.2 million as of October 15, 2026...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Rockwell Medical schedules results. Rockwell Medical stock has USD 32.2 million value

    Rockwell Medical's stock value reached USD 32.2 million as of October 15, 2026, with its Fortune workplace ranking improving significantly from No. 40 in 2025 to No. 16 in 2026. The company is set to announce its...

    ad-hoc-news.de•10/15/26•Neutral

    Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026

    Rockwell Medical (RMTI) announced it will release its third-quarter 2026 financial and operational results on Thursday, November 12, 2026. The company plans to issue a press release at 6:00 a.m. EST...

    Stock Titan•10/15/26•Neutral

    Rockwell Medical to Exhibit at ASN Kidney Week 2026

    Rockwell Medical, Inc. announced its participation in ASN Kidney Week 2026, where it will exhibit its hemodialysis concentrates portfolio. The company...

    Yahoo Finance•10/14/26•Somewhat-Bullish

    Rockwell Medical to Exhibit at ASN Kidney Week 2026

    Rockwell Medical, Inc. announced its participation in the American Society of Nephrology (ASN) Kidney Week 2026...

    StreetInsider•10/14/26•Somewhat-Bullish

    RMTI Valuation and Fair Value

    P/E
    -6.4x
    Forward P/E
    24.6x
    P/FCF
    20.5x
    PEG
    4.4x
    P/B
    0.9x
    See GNG's fair value

    RMTI Profitability: Margins, ROIC and FCF

    Gross margin
    17.7%
    Operating margin
    -6.0%
    Net margin
    -7.3%
    ROIC
    -7.4%
    ROE
    -15.5%
    FCF margin
    2.2%
    FCF yield
    4.9%

    RMTI Competitors

    CompanyTicker
    Briacell Therapeutics CorpBCTX
    CEL-SCI CorpCVM
    Quince Therapeutics, Inc.QNCX
    Milestone ScientificMLSS
    China Pharma Holdings IncCPHI
    Actinium Pharmaceuticals IncATNM
    Elutia Inc.ELUT
    Barinthus Biotherapeutics plcBRNS

    Sector: Healthcare

    RMTI Bull Case vs Bear Case

    Bull case

    • RMTI grew quarterly revenue 10.6% year over year.

    Bear case

    • RMTI has a -7.3% net profit margin.
    • RMTI beat EPS estimates in 37.5% of its last 8 reported quarters.

    RMTI Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    15.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.18
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About RMTI

    Does RMTI pay dividends?

    Rockwell Medical Inc (RMTI) does not currently pay a regular dividend.

    What is RMTI's market cap?

    Rockwell Medical Inc (RMTI) has a market capitalization of $31.64M with a current stock price of $7.98.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In